Cargando…
A cyclic nano-reactor achieving enhanced photodynamic tumor therapy by reversing multiple resistances
BACKGROUND: Photodynamic therapy (PDT) is a clinically implemented modality to combat malignant tumor, while its efficacy is largely limited by several resistance factors from tumor microenvironment (TME), such as hypoxia, anti-oxidant systems, and ATP-dependent tumor adaptive resistances. The aim o...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8139056/ https://www.ncbi.nlm.nih.gov/pubmed/34020663 http://dx.doi.org/10.1186/s12951-021-00893-6 |
_version_ | 1783695928564121600 |
---|---|
author | Liu, Peng Zhou, Yanbin Shi, Xinyi Yuan, Yu Peng, Ying Hua, Surong Luo, Qiange Ding, Jinsong Li, Yong Zhou, Wenhu |
author_facet | Liu, Peng Zhou, Yanbin Shi, Xinyi Yuan, Yu Peng, Ying Hua, Surong Luo, Qiange Ding, Jinsong Li, Yong Zhou, Wenhu |
author_sort | Liu, Peng |
collection | PubMed |
description | BACKGROUND: Photodynamic therapy (PDT) is a clinically implemented modality to combat malignant tumor, while its efficacy is largely limited by several resistance factors from tumor microenvironment (TME), such as hypoxia, anti-oxidant systems, and ATP-dependent tumor adaptive resistances. The aim of this work is to construct a multifunctional nanoplatform to remodel multiple resistant TME for enhanced PDT. RESULTS: Here, a targeting nano-reactor was facilely constructed to reverse the multiple resistances of PDT by incorporating glucose oxidase (GOx) and chlorin e6 (Ce6) into poly (D, L-lactic-co-glycolic acid) (PLGA)/ metalorganic framework (MOF) coreshell nanoassembly, with surface deposition of hyaluronic acid (HA) stabilized MnO(2). The nano-reactor could selectively target tumor cells by virtue of surface HA modification, and once internalization, a few reactions were initiated to modulate TME. Glucose was consumed by GOx to inhibit ATP generation, and the produced H(2)O(2) was catalyzed by MnO(2) to generate O(2) for tumor hypoxia alleviation and photodynamic sensitization, and glutathione (GSH) was also effectively depleted by MnO(2) to suppress the tumor antioxidant defense. Consequently, the nano-reactor achieved robust PDT with amplified tumor therapy via intravenous injection. CONCLUSIONS: This nano-reactor offers a multifunctional nanoplatform to sensitize TME-limited tumor treatment means via reversing multiple resistances. GRPAHIC ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12951-021-00893-6. |
format | Online Article Text |
id | pubmed-8139056 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-81390562021-05-21 A cyclic nano-reactor achieving enhanced photodynamic tumor therapy by reversing multiple resistances Liu, Peng Zhou, Yanbin Shi, Xinyi Yuan, Yu Peng, Ying Hua, Surong Luo, Qiange Ding, Jinsong Li, Yong Zhou, Wenhu J Nanobiotechnology Research BACKGROUND: Photodynamic therapy (PDT) is a clinically implemented modality to combat malignant tumor, while its efficacy is largely limited by several resistance factors from tumor microenvironment (TME), such as hypoxia, anti-oxidant systems, and ATP-dependent tumor adaptive resistances. The aim of this work is to construct a multifunctional nanoplatform to remodel multiple resistant TME for enhanced PDT. RESULTS: Here, a targeting nano-reactor was facilely constructed to reverse the multiple resistances of PDT by incorporating glucose oxidase (GOx) and chlorin e6 (Ce6) into poly (D, L-lactic-co-glycolic acid) (PLGA)/ metalorganic framework (MOF) coreshell nanoassembly, with surface deposition of hyaluronic acid (HA) stabilized MnO(2). The nano-reactor could selectively target tumor cells by virtue of surface HA modification, and once internalization, a few reactions were initiated to modulate TME. Glucose was consumed by GOx to inhibit ATP generation, and the produced H(2)O(2) was catalyzed by MnO(2) to generate O(2) for tumor hypoxia alleviation and photodynamic sensitization, and glutathione (GSH) was also effectively depleted by MnO(2) to suppress the tumor antioxidant defense. Consequently, the nano-reactor achieved robust PDT with amplified tumor therapy via intravenous injection. CONCLUSIONS: This nano-reactor offers a multifunctional nanoplatform to sensitize TME-limited tumor treatment means via reversing multiple resistances. GRPAHIC ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12951-021-00893-6. BioMed Central 2021-05-21 /pmc/articles/PMC8139056/ /pubmed/34020663 http://dx.doi.org/10.1186/s12951-021-00893-6 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Liu, Peng Zhou, Yanbin Shi, Xinyi Yuan, Yu Peng, Ying Hua, Surong Luo, Qiange Ding, Jinsong Li, Yong Zhou, Wenhu A cyclic nano-reactor achieving enhanced photodynamic tumor therapy by reversing multiple resistances |
title | A cyclic nano-reactor achieving enhanced photodynamic tumor therapy by reversing multiple resistances |
title_full | A cyclic nano-reactor achieving enhanced photodynamic tumor therapy by reversing multiple resistances |
title_fullStr | A cyclic nano-reactor achieving enhanced photodynamic tumor therapy by reversing multiple resistances |
title_full_unstemmed | A cyclic nano-reactor achieving enhanced photodynamic tumor therapy by reversing multiple resistances |
title_short | A cyclic nano-reactor achieving enhanced photodynamic tumor therapy by reversing multiple resistances |
title_sort | cyclic nano-reactor achieving enhanced photodynamic tumor therapy by reversing multiple resistances |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8139056/ https://www.ncbi.nlm.nih.gov/pubmed/34020663 http://dx.doi.org/10.1186/s12951-021-00893-6 |
work_keys_str_mv | AT liupeng acyclicnanoreactorachievingenhancedphotodynamictumortherapybyreversingmultipleresistances AT zhouyanbin acyclicnanoreactorachievingenhancedphotodynamictumortherapybyreversingmultipleresistances AT shixinyi acyclicnanoreactorachievingenhancedphotodynamictumortherapybyreversingmultipleresistances AT yuanyu acyclicnanoreactorachievingenhancedphotodynamictumortherapybyreversingmultipleresistances AT pengying acyclicnanoreactorachievingenhancedphotodynamictumortherapybyreversingmultipleresistances AT huasurong acyclicnanoreactorachievingenhancedphotodynamictumortherapybyreversingmultipleresistances AT luoqiange acyclicnanoreactorachievingenhancedphotodynamictumortherapybyreversingmultipleresistances AT dingjinsong acyclicnanoreactorachievingenhancedphotodynamictumortherapybyreversingmultipleresistances AT liyong acyclicnanoreactorachievingenhancedphotodynamictumortherapybyreversingmultipleresistances AT zhouwenhu acyclicnanoreactorachievingenhancedphotodynamictumortherapybyreversingmultipleresistances AT liupeng cyclicnanoreactorachievingenhancedphotodynamictumortherapybyreversingmultipleresistances AT zhouyanbin cyclicnanoreactorachievingenhancedphotodynamictumortherapybyreversingmultipleresistances AT shixinyi cyclicnanoreactorachievingenhancedphotodynamictumortherapybyreversingmultipleresistances AT yuanyu cyclicnanoreactorachievingenhancedphotodynamictumortherapybyreversingmultipleresistances AT pengying cyclicnanoreactorachievingenhancedphotodynamictumortherapybyreversingmultipleresistances AT huasurong cyclicnanoreactorachievingenhancedphotodynamictumortherapybyreversingmultipleresistances AT luoqiange cyclicnanoreactorachievingenhancedphotodynamictumortherapybyreversingmultipleresistances AT dingjinsong cyclicnanoreactorachievingenhancedphotodynamictumortherapybyreversingmultipleresistances AT liyong cyclicnanoreactorachievingenhancedphotodynamictumortherapybyreversingmultipleresistances AT zhouwenhu cyclicnanoreactorachievingenhancedphotodynamictumortherapybyreversingmultipleresistances |